APGE Stock Summary and Trading Ideas (Apogee Therapeutics | NASDAQ:APGE)

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics trades on the NASDAQ stock market under the symbol APGE.

As of January 27, 2026, APGE stock price climbed to $72.38 with 747,428 million shares trading.

APGE has a beta of 0.99, meaning it tends to be less sensitive to market movements. APGE has a correlation of 0.07 to the broad based SPY ETF.

APGE has a market cap of $4.95 billion. This is considered a Mid Cap stock.

The top ETF exchange traded funds that APGE belongs to (by Net Assets): VTI, IWM, XBI, VXF, IBB.

APGE has outperformed the market in the last year with a return of +79.7%, while the SPY ETF gained +15.6%. In the last 3 month period, APGE beat the market returning +35.7%, while SPY returned +3.0%. However, in the most recent 2 weeks APGE has underperformed the stock market by returning -6.8%, while SPY returned 0.0%.

APGE support price is $67.59 and resistance is $72.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APGE shares will trade within this expected range on the day.